Global Neuroendovascular Coil Market 2015-2019
About Neuroendovascular Coil
A neuroendovascular coil is used to treat an unruptured and ruptured brain aneurysm (a weakened area in the artery wall). The treatment is either known as an endovascular coiling or endovascular embolization. During this procedure, the endovascular coil blocks the blood flow in an aneurysm. The endovascular coiling treatment is usually performed under general anaesthesia by an interventional neuroradiologist using fluoroscopic imaging guidance. Neuroendovascular coils are used as an alternative to surgical clipping in the treatment of an aneurysm.
Technavio's analysts forecast the global neuroendovascular coil market to grow at a CAGR of 8.26% over the period 2014-2019.
Covered in this Report
The report includes the present scenario and the growth prospects of the global neuroendovascular coil market for the period 2015-2019.
Technavio's report, Global Neuroendovascular Coil Market 2015-2019, has been prepared based on in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors.Key Regions
Technavio Announces the Publication of its Research Report – Global Neuroendovascular Coil Market 2015-2019
Technavio recognizes the following companies as the key players in the Global Neuroendovascular Coil Market: DePuy Synthes Companies, Medtronic Inc., MicroVention Inc. and Stryker Corp.
Other Prominent Vendors in the market are: Balt Extrusion, Cook Medical, Gore Medical, Merlin MD, Micromar, NeuroVasx, Penumbra, Phenox, Sequent Medical and Valor Medical
Commenting on the report, an analyst from Technavio’s team said: “The increased awareness of neurological coils for severe ICAD, acute ischemic stroke, cerebral aneurysms, and other diseases related to the brain among the medical fraternity has led to an increase in their adoption. Therefore, the market has stepped up the pace of the development of innovative products such as flow catheters that guide the neuroendovascular coils and conform to the aneurysm shape.”
According to the report, minimally invasive endovascular surgeries reduce the length of the hospital stay and allow the patient to recover faster, leading to better utilization of the healthcare resources at an overall lower cost. The minimally invasive nature of these procedures reduces the hospitalization costs, which is expected to increase the demand for these procedures and contribute to the market growth.
Further, the report states that regulatory authorities have imposed a stringent regulatory framework and labeling requirement for medical devices, especially devices used for cardiovascular and neurovascular surgeries. These devices are always considered high-risk and undergo safety examination to demonstrate medical efficacy before they are granted approval.